WHLT 10-K & 10-Q changes, risk factors and insider trading
Chase Packaging Corp. · OTC · Agricultural Services · CIK 1025771 · All filings on SEC.gov
At a glance
What changed in the latest 10-K
Risk Factors
As a smaller reporting company, we are not required to provide the information required by this item.
No wording changes found in this section.
Full comparison: every changed paragraph (0)
Management's Discussion & Analysis (MD&A)
Largest changes
The Company had a net loss of $76,742 for the year ended December 31, 2025, compared with a net loss of $88,949 for the year ended December 31,see in full comparison2024, compared with a net loss of $403,030 for the year ended December 31, 2023.2024. The decrease in net loss was due totheaabove-mentioneddecreaseeffectinofprofessionalthe warrant modification expense.fees.
Othersee in full comparisonexpenseincomeimproveddecreased by$346,709$6,057 for the year ended December 31,20242025 as compared to the year ended December 31,2023.2024. Theimprovementdecrease wascauseddriven bya decrease in warrant modification expenses (See Note 6 on the accompanying financial statements) and moreless interest income in20242025 as compared to20232024dueandto higherlower interest rates.
“The use of cash of $53,072 used in operating activities for the year ended December 31, 2023, principally resulted from our net loss of $403,030, as adjusted for a non-cash charge for warrants modification expense of $345,450.”see in full comparison
At December 31,see in full comparison20242025 the Company had cash and cash equivalents of$297,710,$221,966, consisting ofmoney marketfundsinvestedininbank account and U.S. TreasuryandMoneygovernmentMarketsecurities maturing in 3 months or less.Funds. Management believes that its cash and cash equivalents are sufficient for its business activities for at least the next twelve months and for the costs of seeking an acquisition of an operating business.
The use of cash ofsee in full comparison$90,461$75,744 used in operating activities for the year ended December 31,2024,2025, principally resulted from the net loss of$88,949.$76,742 offset by change in accounts payable and accrued expenses of $998.
“No cash proceeds were used in or provided by financing activities during the years ended December 31, 2024 and 2023.”see in full comparison
Full comparison: every changed paragraph (7)
Operating expenses consist mostly of audit and accounting fees and payroll. There were moreless operating expenses for the year ended December 31, 2024,2025, mainly due to higherlower legal and professional fees incurred in 2024.2025. Other general and administrative expenses are comprised of transfer agent and EDGAR filer services and other services. These expenses were directly related to the maintenance of the corporate entity and the preparation and filing of reports with the Securities and Exchange Commission.
Other expenseincome improveddecreased by $346,709$6,057 for the year ended December 31, 20242025 as compared to the year ended December 31, 2023.2024. The improvementdecrease was causeddriven by a decrease in warrant modification expenses (See Note 6 on the accompanying financial statements) and moreless interest income in 20242025 as compared to 20232024 dueand to higherlower interest rates.
The Company had a net loss of $76,742 for the year ended December 31, 2025, compared with a net loss of $88,949 for the year ended December 31, 2024, compared with a net loss of $403,030 for the year ended December 31, 2023.2024. The decrease in net loss was due to thea above-mentioneddecrease effectin ofprofessional the warrant modification expense.fees.
At December 31, 20242025 the Company had cash and cash equivalents of $297,710,$221,966, consisting of money market funds investedin inbank account and U.S. Treasury andMoney governmentMarket securities maturing in 3 months or less.Funds. Management believes that its cash and cash equivalents are sufficient for its business activities for at least the next twelve months and for the costs of seeking an acquisition of an operating business.
The use of cash of $90,461$75,744 used in operating activities for the year ended December 31, 2024,2025, principally resulted from the net loss of $88,949.$76,742 offset by change in accounts payable and accrued expenses of $998.
The use of cash of $53,072 used in operating activities for the year ended December 31, 2023, principally resulted from our net loss of $403,030, as adjusted for a non-cash charge for warrants modification expense of $345,450.
No cash proceeds were used in or provided by financing activities during the years ended December 31, 2024 and 2023.
What changed in the latest 10-Q
Risk Factors
We could not find a separate Risk Factors item in the latest 10-Q. Some companies leave it out of quarterly reports; see the annual 10-K risk factors and the original filing. Open the filing on SEC.gov.
Management's Discussion & Analysis (MD&A)
New heading “For the six months ended June 30, 2026 and 2025”
New heading “Operating Expenses”
New heading “Loss from Operations”
New heading “Other Income (Expense)”
Largest changes
“Other general and administrative expenses are comprised of OTC registration fee, transfer agent and EDGAR filer services and other services. These expenses were directly related to the maintenance of the corporate entity and the preparation and filing of reports with the Securities and Exchange Commission.”see in full comparison
see in full comparisonNet otherOther income(expense)decreasedwasby$(136,442)$942 for the three months endedMarchJune31,30,2026,2026 as compared tonet other income (expense) of $2,818 forthe three months endedMarchJune31,30, 2025.TheThischangedecreasewasprimarilydueresultedtofromtheaextensionlowerofbankthe warrants’ expiration date resulting in warrants modification expense of $138,180balance during thethreesix months endedMarchJune31,30,2026 (see Note 5 to the financial statements).2025.
Full comparison: every changed paragraph (32)
For the three months ended MarchJune 31,30, 2026 and 2025
The Company had no operations and no revenue for the three months ended MarchJune 31,30, 2026 and 2025, and its only income was from interest income on its short-term investments which are classified as cash and cash equivalents.
The following table presents our total operating expenses for the three months ended MarchJune 31,30, 2026 and 2025.
Operating expenses decreased by $5,935 for the three months ended June 30, 2026 as compared to the three months ended June 30, 2025. The decrease was related to the decrease in other general and administration legal for the three months ended June 30, 2026.
Operating expenses remained constant for the three months ended March 31, 2026 as compared to the three months ended March 31, 2025. Other general and administrative expenses are comprised of OTC registration fee, transfer agent and EDGAR filer services and other services. These expenses were directly related to the maintenance of the corporate entity and the preparation and filing of reports with the Securities and Exchange Commission.
The Company incurred a loss from operations of $17,335$26,521 and $17,325$32,456 for the three months ended MarchJune 31,30, 2026 and 2025, respectively.
The following table presents our total Other Income (Expense) for the three months ended MarchJune 31,30, 2026 and 2025.
Net otherOther income (expense)decreased wasby $(136,442)$942 for the three months ended MarchJune 31,30, 2026,2026 as compared to net other income (expense) of $2,818 for the three months ended MarchJune 31,30, 2025. TheThis changedecrease wasprimarily dueresulted tofrom thea extensionlower ofbank the warrants’ expiration date resulting in warrants modification expense of $138,180balance during the threesix months ended MarchJune 31,30, 2026 (see Note 5 to the financial statements).2025.
The Company had a net loss of $153,777$24,893 for the three months ended MarchJune 31,30, 2026, compared with a net loss of $14,507$29,886 for the three months ended MarchJune 31,30, 2025. The increasedecrease in net loss was due to the above-mentioned warrant-extension-of-expiration-date effect and to a small increasedecrease in other general and administrative expenses.
Loss per share for the three months ended MarchJune 31,30, 2026 and 2025 was approximately $(0.00) and $(0.00) based on the weighted-average shares issued and outstanding.
For the six months ended June 30, 2026 and 2025
Revenue
The Company had no operations and no revenue for the six months ended June 30, 2026 and 2025, and its only income was from interest income on its short-term investments which are classified as cash and cash equivalents.
Operating Expenses
The following table presents our total operating expenses for the six months ended June 30, 2026 and 2025.
Operating expenses decreased by $5,925 for the six months ended June 30, 2026 as compared to the six months ended June 30, 2025. The decrease was related to the decrease in professional fees and other general and administration legal fees for the six months ended June 30, 2026.
Other general and administrative expenses are comprised of OTC registration fee, transfer agent and EDGAR filer services and other services. These expenses were directly related to the maintenance of the corporate entity and the preparation and filing of reports with the Securities and Exchange Commission.
Loss from Operations
The Company incurred a loss from operations of $43,856 and $49,781 for the six months ended June 30, 2026 and 2025, respectively.
Other Income (Expense)
The following table presents our total Other Income (Expense) for the six months ended June 30, 2026 and 2025.
Net other income (expense) was $(134,814) for the six months ended June 30, 2026, compared to net other income (expense) of $5,388 for the six months ended June 30, 2025. The change was due to the extension of the warrants’ expiration date resulting in warrants modification expense of $138,180 during the six months ended June 30, 2026 (see Note 5 to the financial statements).
Net Loss
The Company had a net loss of $178,670 for the six months ended June 30, 2026, compared with a net loss of $44,393 for the six months ended June 30, 2025. The increase in net loss was mainly due to the above-mentioned warrants modification expense.
Loss per share for the six months ended June 30, 2026 and 2025 was approximately $(0.00) and $(0.00) based on the weighted-average shares issued and outstanding.
It is anticipated that future operating expenses will decrease and then stabilize as the Company complies with its periodic reporting requirements; however, expenses may increase as the Company works to effect a business combination, although there can be no assurance that the Company will be successful in effecting a business combination.
At MarchJune 31,30, 2026 the Company had cash and cash equivalents of $206,369,$180,726, consisting of money market funds and U.S. Treasury and government securities maturing in 3 months or less. Management believes that its cash and cash equivalents are sufficient for its business activities for at least the next twelve months and for the costs of seeking an acquisition of an operating business.
Net cash of $15,597$41,240 and $13,679$44,393 were used in operations during the threesix months ended MarchJune 31,30, 2026 and 2025, respectively.
The cash used in operating activities of $15,597$41,240 for the threesix months ended MarchJune 31,30, 2026 principally resulted from our net loss of $153,777$178,670 offset by change in warrants modification expense of $138,180.$138,180 and change in accounts payable and accrued expenses of $750.
The cash used in operating activities of $13,679$44,393 for the threesix months ended MarchJune 31,30, 2025 principally resulted from our net loss of $14,507 offset by change in accounts payable and accrued expenses of $828.$44,393.
No cash flows were used in or provided by investing activities during the threesix months ended MarchJune 31,30, 2026 and 2025.
No cash flows were used in or provided by financing activities during the threesix months ended MarchJune 31,30, 2026 and 2025.
WHLT insider buying and selling (Form 4)
Since 2026-04-11, insiders reported open-market purchases in 0 Form 4 filings and open-market sales in 0 filings. Totals add up every open-market (code P and S) line in those filings, using the prices reported in the filings. Awards, option exercises, tax withholding and gifts are listed below but not counted.
No Form 4 stock transactions in this period.
Well-known investors holding WHLT (13F)
None of the 59 investors we track reported a position in their latest 13F.